Latest News
Pontiff’s has led a EUR87 million Series A funding round in biotech company Emergence Therapeutics.
Existing and new investors also participated along with the Emergence Therapeutics management team which was advices by ARQIS.
Proceeds from this funding round will be used to advance the company’s next-generation antibody drug conjugate (ADC) targeting Nectin-4 to clinical proof-of-concept as well as the development of additional ADC programs. Antibody drug conjugates are among the most promising areas of research in the fight against cancer.
MVI Advisors AB (MVI) has held the final closing of its second private equity fund, MVI Fund II AB (Fund II) with commitments of SEK1.1 billion, exceeding its target of SEK1 billion.
MVI’s previous fund, MVI Fund I AB (“Fund I”), had commitments of SEK 478 million.
The Fund, led by Stefan Karlsson and Daniel Nilsson, is pursuing the successful strategy implemented by MVI since 2011 of completing buyout investments in high-quality, small companies in the Nordic region, with a particular focus on Sweden. Its focus will be to acquire control positions in companies that take advantage of sustainable industry
Muzinich & Co SGR, acting on behalf of Azimut ELTIF Capital Solutions Strategy, has invested EUR18 million in Italian textile producer Canepa.
A significant 88 per cent of Limited Partners (LPs) surveyed in the Brackendale Private Equity Corporate Identity LP Sentiment Survey H2 2021, says that even if a private equity fund was producing strong returns, it would matter to them if it had badly designed or poorly written investor marketing materials.
A lack of professionalism in wording and design suggests the GPs are not focused on their investors, makes it hard to understand their uniqueness and competitive advantages, and speaks of incompetence or arrogance, according to some of the comments made by LP fund investors.
A hefty 94 per cent
Consumer growth investor Active Partners, with participation from existing angel investors, including John Ayton, Christian Woolfenden and Matt Barker, have invested GBP4 million in Subdial, a platform for trading pre-owned luxury watches.
The fresh funds from Active Partners will be used to enhance the digital experience for collectors, helping them navigate the platform more easily, as well as to bolster international expansion to accommodate demand.
eCOGRA, an independent and internationally approved testing and certification agency for the online gambling industry, has been acquired by Hanover Investors.
eCOGRA focuses on using its in-house certification methodologies and expertise to enable player protection, fair gaming and responsible conduct by operators and software providers through its Generally Accepted Practices (eGAP).
eCOGRA offers testing and inspection services, cybersecurity assessment, product certification and accredited ISO/IEC 27001 information security management certification. It is an approved testing agency and certification body for more than 30 jurisdictions across Europe, North and South America and Asia. It has also been approved to provide alternative dispute
Norwest Venture Partners, a venture capital and growth equity investment firm, has closed a USD3 billion fund, Norwest Venture Partners XVI, LP.
The new fund will target innovative companies with transformational businesses, empowering its portfolio leaders with the resources and connections to enhance their growth and create sustainable value. NVP XVI brings the firm’s total capital under management to USD12.5 billion.
German venture capital firm MIG Capital AG has closed a EUR22.5 million Series B funding round for Mimi Hearing Technologies, a specialist in hearing wellbeing and audio personalisation software.
The funding round is led by MIG Capital in a consortium with a larger Munich-based family office and Salvia, the family office of Helmut Jeggle, along with additional German family offices and existing shareholders.
Mimi licenses its science-based hearing enhancement technology to B2B customers including electronic device manufacturers and streaming providers. The additional funding significantly enhances their successful and ongoing efforts to deliver better and healthier hearing experiences to millions of
Depixus, a biotechnology company developing technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins, has raised EUR30.6 million in an oversubscribed Series A financing.
Global real estate investment company Kennedy Wilson’s debt investment platform now exceeds USD2 billion in real-estate secured loans, including USD300 million in future funding commitments.
Kennedy Wilson reached the milestone following the launch of the debt platform in 2020 and a subsequent expansion into Europe in mid-2021. The company’s global debt platform is targeting USD3 billion in total loan investments. Since January 2021, the Company has originated approximately USD1.4 billion in loans while achieving USD260 million in loan repayments.
Kennedy Wilson invests alongside its strategic partners with an average ownership of 7.5 per cent across the debt portfolio, which is
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
